Insights into artificial intelligence-based digital pathology in hepatobiliary and pancreatic cancer
Artificial intelligence (AI)-driven digital pathology has emerged as a promising approach for improving diagnosis, prognostic assessment, and treatment decision-making in hepatobiliary and pancreatic cancers (HPCs). By leveraging whole-slide imaging and deep learning, AI enables high-throughput and reproducible analysi...